REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
MOGRIFY
ST13
US500000079289697Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Rebecca Liebowitz Venable LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
Classe 5
Medical and veterinary preparations for therapeutic purposes, namely pharmaceutical and biopharmaceutical preparations for the treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; pharmaceutical and biopharmaceutical preparations for cell therapy; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; biological, chemical and biochemical reagents for medical use
Classe 9
Downloadable bioinformatics software for genomic data analysis; downloadable computer software platforms for genomic data analysis in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; scientific apparatus for measuring and analysing scientific study data in the nature of apparatus for recording, transmission or reproduction of data including video, audio, images and text; data analysis apparatus in the nature of data processing equipment and computers and downloadable operating computer software sold as a unit; downloadable scientific data analysis software
Classe 40
Treatment and processing of biological materials, namely cells, stem cells, induced pluripotent stem cells; custom manufacture of therapeutic drugs, namely custom manufacture of transcription factors, cells and cell therapies, gene therapies ; information, advisory and consultancy services in relation to all of the aforesaid services
Classe 42
Scientific and technological services, namely, research and design in the fields of ophthalmology, haematology, immunology, neurology, respiratory diseases, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; industrial research services in the field of cell therapies and gene therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services; software as a service (SaaS) services featuring software for use in genomic data analysis; platform as a service (Paas) services that feature a computer bioinformatics platform for use in manufacturing therapeutics; providing a bioinformatics platform for identifying transcription factors to turn one cell type into another cell type; advisory and consultancy relating to all the aforesaid services
Classe 44
Medical services; veterinary services; medical services for the treatment of conditions of the human or animal body; medical services in the nature of manipulation of human and animal cells for therapeutic purposes; providing advice and consultancy in the field of medical and veterinary therapies
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/07/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
04/01/2022
FINAL DISPOSITION NOTICE SENT TO IB
13/12/2021
FINAL DISPOSITION PROCESSED
13/12/2021
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/10/2021
REGISTERED-PRINCIPAL REGISTER
27/07/2021
NOTIFICATION PROCESSED BY IB
11/05/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/05/2021
PUBLISHED FOR OPPOSITION
11/05/2021
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/04/2021
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/04/2021
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/04/2021
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2021
EXAMINER'S AMENDMENT ENTERED
02/04/2021
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/04/2021
EXAMINERS AMENDMENT E-MAILED
02/04/2021
EXAMINERS AMENDMENT -WRITTEN
02/04/2021
NOTIFICATION OF FINAL REFUSAL EMAILED
25/03/2021
FINAL REFUSAL E-MAILED
25/03/2021
FINAL REFUSAL WRITTEN
25/03/2021
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2021
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/03/2021
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2021
REFUSAL PROCESSED BY IB
04/10/2020
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/09/2020
REFUSAL PROCESSED BY MPU
11/09/2020
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/08/2020
NON-FINAL ACTION WRITTEN
11/08/2020
ASSIGNED TO EXAMINER
10/08/2020
APPLICATION FILING RECEIPT MAILED
25/07/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/07/2020
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/07/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.